Business Context and Reporting Period
This Form 8-K Current Report was filed by Glaukos Corporation on February 6, 2017. The filing primarily addresses a significant executive leadership change within the company's financial management team.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
- New CFO Base Salary: $360,000 annually.
- Target Bonus: Up to 50% of base salary.
- Equity Grant: 300,000 stock options and 100,000 restricted stock units (subject to Board approval and adjustment).
Material Changes
The primary material change is the appointment of Joseph E. Gilliam as Chief Financial Officer (CFO) and Senior Vice President, Corporate Development. Mr. Gilliam is scheduled to start in May 2017, replacing current CFO Richard Harrison, who is retiring later in 2017. Mr. Gilliam previously served as Managing Director of Healthcare Investment Banking at JPMorgan Chase.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of operational risks. It includes a Regulation FD disclosure referencing a press release regarding the appointment, which is attached as an exhibit but not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the exact start date of Joseph E. Gilliam in May 2017.
- Confirm the final terms of the equity grant (300,000 options and 100,000 RSUs) upon Board approval.
- Review the attached Offer Letter (Exhibit 99.2) for specific performance objectives tied to the bonus structure.
- Monitor the transition timeline for the departure of Richard Harrison.